AAAAAA

   
Results: 1-19 |
Results: 19
Mortality rates in comparative trials of formulations of amphotericin B - Reply
Authors: Wingard, JR White, MH Anaissie, E Buell, D
Citation: Jr. Wingard et al., Mortality rates in comparative trials of formulations of amphotericin B - Reply, CLIN INF D, 33(4), 2001, pp. 583-584
Revisiting the source of candidemia: Skin or gut?
Authors: Nucci, M Anaissie, E
Citation: M. Nucci et E. Anaissie, Revisiting the source of candidemia: Skin or gut?, CLIN INF D, 33(12), 2001, pp. 1959-1967
Thalidomide in the management of multiple myeloma
Authors: Barlogie, B Tricot, G Anaissie, E
Citation: B. Barlogie et al., Thalidomide in the management of multiple myeloma, SEMIN ONCOL, 28(6), 2001, pp. 577-582
Thalidomide in the management of multiple myeloma
Authors: Barlogie, B Zangari, M Spencer, T Fassas, A Anaissie, E Badros, A Cromer, J Tricot, G
Citation: B. Barlogie et al., Thalidomide in the management of multiple myeloma, SEM HEMATOL, 38(3), 2001, pp. 250-259
Results of autologous stem cell transplant in multiple myeloma patients with renal failure
Authors: Badros, A Barlogie, B Siegel, E Roberts, J Langmaid, C Zangari, M Desikan, R Shaver, MJ Fassas, A McConnell, S Muwalla, F Barri, Y Anaissie, E Munshi, N Tricot, G
Citation: A. Badros et al., Results of autologous stem cell transplant in multiple myeloma patients with renal failure, BR J HAEM, 114(4), 2001, pp. 822-829
Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years
Authors: Badros, A Barlogie, B Siegel, E Morris, C Desikan, R Zangari, M Fassas, A Anaissie, E Munshi, N Tricot, G
Citation: A. Badros et al., Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years, BR J HAEM, 114(3), 2001, pp. 600-607
Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone
Authors: Desikan, KR Tricot, G Munshi, NC Anaissie, E Spoon, D Fassas, A Toor, A Zangari, M Badros, A Morris, C Vesole, DH Siegel, D Jagannath, S Barlogie, B
Citation: Kr. Desikan et al., Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone, BR J HAEM, 112(1), 2001, pp. 242-247
Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy
Authors: Zangari, M Anaissie, E Barlogie, B Badros, A Desikan, R Gopal, AV Morris, C Toor, A Siegel, E Fink, L Tricot, G
Citation: M. Zangari et al., Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy, BLOOD, 98(5), 2001, pp. 1614-1615
Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 studyof 169 patients
Authors: Barlogie, B Desikan, R Eddlemon, P Spencer, T Zeldis, J Munshi, N Badros, A Zangari, M Anaissie, E Epstein, J Shaughnessy, J Ayers, D Spoon, D Tricot, G
Citation: B. Barlogie et al., Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 studyof 169 patients, BLOOD, 98(2), 2001, pp. 492-494
A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia
Authors: Wingard, JR White, MH Anaissie, E Raffalli, J Goodman, J Arrieta, A
Citation: Jr. Wingard et al., A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia, CLIN INF D, 31(5), 2000, pp. 1155-1163
Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone
Authors: Desikan, KR Tricot, G Dhodapkar, M Fassas, A Siegel, D Vesole, DH Jagannath, S Singhal, S Mehta, J Spoon, D Anaissie, E Barlogie, B Munshi, N
Citation: Kr. Desikan et al., Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone, BONE MAR TR, 25(5), 2000, pp. 483-487
Stem cell transplantation for multiple myeloma - 10 years later
Authors: Siegel, DS Lim, SH Tricot, G Desikan, KR Fassas, A Mehta, J Singhal, S Anaissie, E Jagannath, S Barlogie, B
Citation: Ds. Siegel et al., Stem cell transplantation for multiple myeloma - 10 years later, HEMATOPOIETIC STEM CELL TRANSPLANTION, 2000, pp. 499-516
Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis
Authors: Wingard, JR Kubilis, P Lee, L Yee, G White, M Walshe, L Bowden, R Anaissie, E Hiemenz, J Lister, J
Citation: Jr. Wingard et al., Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis, CLIN INF D, 29(6), 1999, pp. 1402-1407
Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy
Authors: Aslan, T Fassas, AT Desikan, R Siegel, D Munshi, NC Mehta, J Singhal, S Barlogie, B Anaissie, E
Citation: T. Aslan et al., Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy, BONE MAR TR, 24(5), 1999, pp. 505-509
Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapy
Authors: Singhal, S Mehta, J Desikan, K Siegel, D Singh, J Munshi, N Spoon, D Anaissie, E Ayers, D Barlogie, B
Citation: S. Singhal et al., Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapy, BONE MAR TR, 24(1), 1999, pp. 13-17
Antitumor activity of thalidomide in refractory multiple myeloma.
Authors: Singhal, S Mehta, J Desikan, R Ayers, D Roberson, P Eddlemon, P Munshi, N Anaissie, E Wilson, C Dhodapkar, M Zeldis, J Barlogie, B Siegel, D Crowley, J
Citation: S. Singhal et al., Antitumor activity of thalidomide in refractory multiple myeloma., N ENG J MED, 341(21), 1999, pp. 1565-1571
High-dose therapy with autologous haemopoietic stem cell support for Waldenstrom's macroglobulinaemia
Authors: Desikan, R Dhodapkar, M Siegel, D Fassas, A Singh, J Singhal, S Mehta, J Vesole, D Tricot, G Jagannath, S Anaissie, E Barlogie, B Munshi, NC
Citation: R. Desikan et al., High-dose therapy with autologous haemopoietic stem cell support for Waldenstrom's macroglobulinaemia, BR J HAEM, 105(4), 1999, pp. 993-996
Age is not a prognostic variable with autotransplants for multiple myeloma
Authors: Siegel, DS Desikan, KR Mehta, J Singhal, S Fassas, A Munshi, N Anaissie, E Naucke, S Ayers, D Spoon, D Vesole, D Tricot, G Barlogie, B
Citation: Ds. Siegel et al., Age is not a prognostic variable with autotransplants for multiple myeloma, BLOOD, 93(1), 1999, pp. 51-54
Total therapy with tandem transplants for newly diagnosed multiple myeloma
Authors: Barlogie, B Jagannath, S Desikan, KR Mattox, S Vesole, D Siegel, D Tricot, G Munshi, N Fassas, A Singhal, S Mehta, J Anaissie, E Dhodapkar, D Naucke, S Cromer, J Sawyer, J Epstein, J Spoon, D Ayers, D Cheson, B Crowley, J
Citation: B. Barlogie et al., Total therapy with tandem transplants for newly diagnosed multiple myeloma, BLOOD, 93(1), 1999, pp. 55-65
Risultati: 1-19 |